Biotechnologie

Inovio Pharmaceuticals held its first-quarter 2026 earnings call on May 13 to discuss financial results for the period ended March 31 and provide updates on its DNA medicines platform.

14. Mai 2026 Von KI berichtet

Pulse Biosciences outlined its progress with nanosecond pulsed field ablation technology during a presentation at the Bank of America Global Healthcare Conference on May 13.

Researchers from the University of Barcelona and the University of Oregon report that short DNA molecules known as polypurine reverse Hoogsteen hairpins (PPRHs) suppressed the PCSK9 gene and reduced blood cholesterol in a mouse model. In transgenic mice carrying the human PCSK9 gene, a single injection of one candidate (HpE12) cut plasma PCSK9 by 50% and total cholesterol by 47% three days later, according to findings published in Biochemical Pharmacology.

30. April 2026 Von KI berichtet

Illumina Inc. conducted its first-quarter 2026 earnings conference call on April 30, 2026, at 4:30 PM EDT. CEO Jacob Thaysen and CFO Ankur Dhingra presented updates on the business and financial results. The company released its earnings after market close, available on its investor relations website.